Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues $ 32,867 $ 31,698
Cost of sales 27,696 24,221
Gross margin 5,171 7,477
Operating expenses:    
Selling, general and administrative expenses 20,951 11,256
Transaction expenses 46 2,417
Research and development 1,724 996
Operating income (loss) (17,550) (7,192)
Interest expense, net 1,452 1,421
Other (income) expense, net 1,180 87
Income (loss) before income taxes (20,182) (8,700)
Income tax expense (benefit) (2,889) (1,026)
Net income (loss) $ (17,293) $ (7,674)
Net income (loss) per share, diluted (in dollars per share) $ (0.28) $ (0.21)
Net income (loss) per share, basic (in dollars per share) $ (0.28) $ (0.21)
Weighted-average shares outstanding:    
Basic (in shares) 62,690,869 37,200,000
Diluted (in shares) 62,690,869 37,200,000
Comprehensive income (loss):    
Foreign currency translation gain (loss), net of tax $ (128) $ (231)
Total other comprehensive income (loss), net of tax (128) (231)
Total comprehensive income (loss) $ (17,421) $ (7,905)